Proprotein Convertase Subtilisin/kexin Type 9 抗体
(Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9))
This gene encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. The encoded protein is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the endoplasmic reticulum. The protein may function as a proprotein convertase. This protein plays a role in cholesterol homeostasis and may have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a third form of autosomal dominant familial hypercholesterolemia (HCHOLA3). [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PCSK9 抗体 (AA 454-679) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 454-679) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant PCSK9 抗体 | 人 | Human, 兔 Chimeric |
|
|
|
| PCSK9 抗体 | 人 | 小鼠 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 164-175) | 人 | 山羊 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 153-344) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 671-687) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 156-461) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PCSK9 抗体 (AA 231-330) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 454-679
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 454-679
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- DMC222
- 标记
- unconjugated
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 164-175
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 153-344
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 671-687
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 156-461
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 231-330
Latest Publications for our Proprotein Convertase Subtilisin/kexin Type 9 抗体
: "Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained." in: The Journal of biological chemistry, Vol. 293, Issue 19, pp. 7329-7343, (2019) (PubMed).
: "Proprotein Convertase Subtilisin/Kexin Type 9 Is Associated with Degenerating Adipocytes in Abdominal Aortic Aneurysm." in: Journal of oleo science, Vol. 67, Issue 10, pp. 1355-1360, (2018) (PubMed).
: "Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats." in: Molecular medicine reports, Vol. 13, Issue 6, pp. 4627-35, (2016) (PubMed).
: "Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism." in: The Journal of biological chemistry, Vol. 292, Issue 4, pp. 1510-1523, (2016) (PubMed).
: "Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta." in: Biology of reproduction, Vol. 88, Issue 1, pp. 16, (2013) (PubMed).
: "The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1." in: Molecular biology of the cell, Vol. 21, Issue 12, pp. 2087-96, (2010) (PubMed).
: "Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes." in: Pharmacogenetics and genomics, Vol. 20, Issue 7, pp. 455-8, (2010) (PubMed).
: "Molecular basis for LDL receptor recognition by PCSK9." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 6, pp. 1820-5, (2008) (PubMed).
: "Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment." in: Clinical chemistry, Vol. 54, Issue 6, pp. 1038-45, (2008) (PubMed).
: "PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans." in: The FEBS journal, Vol. 275, Issue 13, pp. 3480-93, (2008) (PubMed).
: "Proprotein Convertase Subtilisin/Kexin Type 9 Is Associated with Degenerating Adipocytes in Abdominal Aortic Aneurysm." in: Journal of oleo science, Vol. 67, Issue 10, pp. 1355-1360, (2018) (PubMed).
: "Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats." in: Molecular medicine reports, Vol. 13, Issue 6, pp. 4627-35, (2016) (PubMed).
: "Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism." in: The Journal of biological chemistry, Vol. 292, Issue 4, pp. 1510-1523, (2016) (PubMed).
: "Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta." in: Biology of reproduction, Vol. 88, Issue 1, pp. 16, (2013) (PubMed).
: "The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1." in: Molecular biology of the cell, Vol. 21, Issue 12, pp. 2087-96, (2010) (PubMed).
: "Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes." in: Pharmacogenetics and genomics, Vol. 20, Issue 7, pp. 455-8, (2010) (PubMed).
: "Molecular basis for LDL receptor recognition by PCSK9." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 6, pp. 1820-5, (2008) (PubMed).
: "Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment." in: Clinical chemistry, Vol. 54, Issue 6, pp. 1038-45, (2008) (PubMed).
: "PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans." in: The FEBS journal, Vol. 275, Issue 13, pp. 3480-93, (2008) (PubMed).
Aliases for Proprotein Convertase Subtilisin/kexin Type 9 抗体
proprotein convertase subtilisin/kexin type 9 (PCSK9) 抗体proprotein convertase subtilisin/kexin type 9 L homeolog (pcsk9.L) 抗体
proprotein convertase subtilisin/kexin type 9 (pcsk9) 抗体
proprotein convertase subtilisin/kexin type 9 (Pcsk9) 抗体
AI415265 抗体
AI747682 抗体
FH3 抗体
HCHOLA3 抗体
LDLCQ1 抗体
NARC-1 抗体
NARC1 抗体
Narc1 抗体
PC9 抗体
您还需要查找其他产品吗？
- Propionyl CoA Carboxylase, alpha Polypeptide 抗体
- PROP1 抗体
- Prominin 2 抗体
- Proline Rich 15-Like 抗体
- Proline Rich 15 抗体
- Proline Rich 13 抗体
- Proliferating Cell Nuclear Antigen 抗体
- Prolactin Receptor 抗体
- Prolactin 抗体
- PROL1 抗体
- Prokineticin Receptor 2 抗体
- Prokineticin Receptor 1 抗体
- Prokineticin 1 抗体
- PROK2 抗体
- Prohibitin 2 抗体
- Prohibitin 抗体
- ProGRP 抗体
- Programmed Cell Death 4 抗体
- Programmed Cell Death 10 抗体
- Programmed Cell Death 1 Ligand 2 抗体
- Prosaposin 抗体
- PROSC 抗体
- PROSER1 抗体
- Prostacyclin Receptor 抗体
- Prostaglandin D2 Receptor 2 抗体
- Prostaglandin E Receptor 2 (Subtype EP2), 53kDa 抗体
- Prostaglandin E Synthase 抗体
- Prostaglandin F2alpha 抗体
- Prostaglandin-Endoperoxide Synthase 2 (Prostaglandin G/H Synthase and Cyclooxygenase) 抗体
- Prostate Specific Antigen 抗体
- Proteasome Subunit alpha 7 抗体
- Proteasome Subunit alpha 6 抗体
- Protein A 抗体
- Protein Arginine Methyltransferase 1 抗体
- Protein B-Myc 抗体
- Protein G 抗体
- Protein Kinase C, alpha 抗体
- Protein Kinase C, beta 1 抗体
- Protein Kinase C, delta 抗体
- Protein Kinase C, epsilon 抗体
You are here:
